Latest Articles
The Fragmented Nightmare of Modern Drug Discovery Ends Here. We've Been Building EMET for a Decade. Here It Is.
company
EMET now reasons over your own data. The best evidence for your next decision is the data you already own. Now EMET can reason over it.
updates
Your target program shouldn't live in chat history
company
BenchSci Names Former Pfizer R&D Chief Dr. Mikael Dolsten as Chairman of the Board
company
The Fragmented Nightmare of Modern Drug Discovery Ends Here. We've Been Building EMET for a Decade. Here It Is.
company
Scientific Integrity by Design: Engineering Disciplined AI for Preclinical R&D
insights
Trust in the Age of Modern AI: Why Design Principles Matter More Than Ever
insights
AI at BenchSci: What We Learned Building Real Impact in 2025
insights
What Does "Good” Look Like: Scaling Evaluation of Non-Deterministic GenAI Systems in Disease Biology Research
insights
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
press